Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016-Reference-Cited by-同舟云学术

Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016

Published:2018-05 Issue:5 Volume:24 Page:895-908
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Al Malki Monzr M.,Jones Richard,Ma Qing,Lee Dean,Reisner Yair,Miller Jeffrey S.,Lang Peter,Hongeng Suradej^ORCID,Hari Parameswaran,Strober Samuel,Yu Jianhua,Maziarz Richard,Mavilio Domenico,Roy Denis-Claude,Bonini Chiara,Champlin Richard E.,Fuchs Ephraim J.,Ciurea Stefan O.^ORCID

Funder

Kiadis Pharma

Miltenyi Biotec

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference120 articles.

1. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report;Passweg;Bone Marrow Transplant,2017

2. One million haemopoietic stem-cell transplants: a retrospective observational study;Gratwohl;Lancet Haematol,2015

3. Haploidentical hematopoietic cell transplantation using post-transplantation cyclophosphamide: does graft source matter?;Devine;J Clin Oncol,2017

4. The induction of graft versus host disease in mice treated with cyclophosphamide;Owens;J Exp Med,1968

5. Production of graft-versus-host disease in the rat and its treatment with cytotoxic agents;Santos;Nature,1966

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders;International Journal of Molecular Sciences;2024-06-09

2. Chemotherapeutic Agents Used in Stem Cell Transplant;Basics of Hematopoietic Stem Cell Transplant;2023

3. Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia;Frontiers in Immunology;2022-11-15

4. Features of Epstein–Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen;Frontiers in Cellular and Infection Microbiology;2022-05-16

5. An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes;Cytotherapy;2022-04